Bridge Biotherapeutics, Inc. Share Price
Equities
A288330
KR7288330004
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,330 KRW | +10.17% | -43.24% | -29.07% |
Sales 2022 | 3.02B 2.22M 177M | Sales 2023 | 100M 73.3K 5.85M | Capitalization | 73.11B 53.59M 4.27B |
---|---|---|---|---|---|
Net income 2022 | -41.7B -30.57M -2.44B | Net income 2023 | -42.32B -31.02M -2.47B | EV / Sales 2022 | 60.4 x |
Net cash position 2022 | 48.29B 35.39M 2.82B | Net cash position 2023 | 16.64B 12.19M 973M | EV / Sales 2023 | 565 x |
P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-1.6
x | Employees | 43 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.49% |
1 day | +10.17% | ||
1 week | -43.24% | ||
Current month | -55.45% | ||
1 month | -55.45% | ||
3 months | -13.38% | ||
6 months | -37.45% | ||
Current year | -29.07% |
Managers | Title | Age | Since |
---|---|---|---|
Jeong-Gyu Lee
FOU | Founder | 56 | 16/09/15 |
Sujin Jung
COO | Chief Operating Officer | - | - |
Sang-Wook Kang
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Seung-Yeob Baek
BRD | Director/Board Member | 64 | - |
Seung-Hoon Lee
BRD | Director/Board Member | 62 | - |
Jeong-Gyu Lee
FOU | Founder | 56 | 16/09/15 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 2,175 | -6.65% | 675,077 |
30/04/24 | 2,330 | +10.17% | 4,182,002 |
29/04/24 | 2,115 | -10.00% | 1,424,955 |
26/04/24 | 2,350 | -0.42% | 2,476,652 |
25/04/24 | 2,360 | -10.61% | 2,249,018 |
End-of-day quote Korea S.E., April 29, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.07% | 41.06M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- A288330 Stock